SlideShare a Scribd company logo
How are countries in Europe and Central Asia
performing against the UNAIDS 90-90-90 Targets?
Teymur Noori and Anastasia Pharris
European Centre for Disease Prevention and Control
EACS 2017
25-27 October, 2017
Fast Track Targets by 2020
73%
of all people living
with HIV
VIRALLY
SUPPRESSED
=
Target 1 Target 2 Target 3 Overall target
diagnosed with HIV
ON ART
living with HIV
DIAGNOSED
on ART
VIRALLY
SUPPRESSED
Fast Track Targets by 2020
73%
of all people living
with HIV
VIRALLY
SUPPRESSED
=
Target 1 Target 2 Target 3
diagnosed with HIV
ON ART
living with HIV
DIAGNOSED
on ART
VIRALLY
SUPPRESSED
Overall target
Progress toward achieving the first 90:
Target 1: 90% of all PLHIV who know their status (n=36)
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
UNAIDS target 90%
Regional average 75%
Progress toward achieving the first 90:
Target 1: 90% of all PLHIV who know their status (n=36)
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
UNAIDS target 90%
EU/EEA average 83%
Non-EU average 58%
Source: ECDC/WHO Europe (2016). HIV/AIDS Surveillance in Europe, 2015
Too many people living with HIV are
diagnosed late
*CD4<350 at diagnosis
Are new innovative approaches to HIV testing
included in national HIV testing guidelines? (n=47)
Testing types Yes No
No
guidelines
Community-based testing delivered by
trained medical staff
27 10 10
Community-based testing delivered by non-
medical staff (e.g. trained lay people)
11 26 10
Home-sampling kits 3 34 10
Self-testing kits 2 35 10
Source: ECDC. HIV testing in Europe. Stockholm: ECDC; 2017.
Fast Track Targets by 2020
73%
of all people living
with HIV
VIRALLY
SUPPRESSED
=
Target 1 Target 2 Target 3
diagnosed with HIV
ON ART
living with HIV
DIAGNOSED
on ART
VIRALLY
SUPPRESSED
Overall target
Progress toward achieving the second 90:
Target 2: 90% of those diagnosed on ART (n=40)
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Regional average 78%
UNAIDS target 90%
Progress toward achieving the second 90:
Target 2: 90% of those diagnosed on ART (n=40)
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
UNAIDS target 90%
EU/EEA average 85%
Non-EU average 53%
Policies on ART initiation in European countries
2014 (n=48)
2015
Source: ECDC. HIV treatment and care. Stockholm: ECDC; 2017.
4
29
15
1028
8
1
0
5
10
15
20
25
30
35
40
45
50
2014 2016
Numberofcountries/ARTpolicy
200 cells/mm3
350 cells/mm3
500 cells/mm3
Initiation regardless
of CD4 count
Policies on ART initiation in European countries
2014 (n=48)
2015
Source: ECDC. HIV treatment and care. Stockholm: ECDC; 2017.
4
29
15
1028
8
1
0
5
10
15
20
25
30
35
40
45
50
2014 2016
Numberofcountries/ARTpolicy
200 cells/mm3
350 cells/mm3
500 cells/mm3
Initiation regardless
of CD4 count
Policies on ART initiation in European countries
2014 (n=48) and 2016 (n=47)
2015
Source: ECDC. HIV treatment and care. Stockholm: ECDC; 2017.
4
29
15
1028
8
1
0
5
10
15
20
25
30
35
40
45
50
2014 2016
Numberofcountries/ARTpolicy
200 cells/mm3
350 cells/mm3
500 cells/mm3
Initiation regardless
of CD4 count
Availability of ART for undocumented migrants, 2016
Source: ECDC. From Dublin to Rome: ten years of responding to HIV in Europe and Central Asia: Stockholm, ECDC; 2014
Source: ECDC. HIV and migrants. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia:
2017 progress report Stockholm: ECDC; 2017.
Fast Track Targets by 2020
73%
of all people living
with HIV
VIRALLY
SUPPRESSED
=
Target 1 Target 2 Target 3
diagnosed with HIV
ON ART
living with HIV
DIAGNOSED
on ART
VIRALLY
SUPPRESSED
Overall target
Progress toward achieving the third 90:
Target 3: 90% of those on ART virally suppressed (n=31)
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Regional average 88%
UNAIDS target 90%
Progress toward achieving the third 90:
Target 3: 90% of those on ART virally suppressed (n=31)
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
UNAIDS target 90%
EU/EEA average 89%
Non-EU average 71%
Fast Track Targets by 2020
73%
of all people living
with HIV
VIRALLY
SUPPRESSED
=
Target 1 Target 2 Target 3
diagnosed with HIV
ON ART
living with HIV
DIAGNOSED
on ART
VIRALLY
SUPPRESSED
Overall target
Progress toward achieving the 90-90-90:
Target 4: 73% of all PLHIV virally suppressed (n=29)
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Regional average 60%
UNAIDS target 73%
Progress toward achieving the 90-90-90:
Target 4: 73% of all PLHIV virally suppressed (n=29)
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
UNAIDS target 73%
EU/EEA average 65%
Non-EU average 24%
Rate of new HIV diagnoses
EU/EEA vs. non-EU/EEA countries, 2006–2015
+105%
Source: ECDC/WHO Europe (2016). HIV/AIDS Surveillance in Europe, 2015
Can we produce an EU continuum of care
estimate based on country reported data?
 Variability of data availability, quality, sources and measurement
have historically made it difficult to compare and combine results
across countries
 But…
EuroCoord/ECDC collaboration on estimating
the continuum of care
 ECDC project with UCL &
EuroCoord on estimating the
continuum of care using
surveillance and cohort data
 Using standard definitions and
high quality data sources
Gourlay A, Noori T, Pharris A. et al. The HIV continuum of care in European Union countries in 2013: data and
challenges. Clin Infect Dis 2017 cix212. doi: 10.1093/cid/cix212
PLHIV Diagnosed On ART Viral suppression
Clinical/
cohort data
Public health/
surveillance data
Bringing together HIV surveillance and clinical data
Country Surveillance leads Cohort leads
Austria Daniela Schmid/Alexander Spina Robert Zangerle
Belgium Andre Sasse/Dominique Van Beckhoven Andre Sasse/Dominique Van Beckhoven
Denmark Susan Cowan Niels Obel
France Florence Lot/Francoise Cazein Dominique Costagliola/Virginie Supervie
Germany Barbara Gunsenheimer-Bartmeyer Barbara Gunsenheimer-Bartmeyer
Greece Georgios Nikolopoulos Giota Touloumi
Italy Barbara Suligoi Antonella d’ Arminio Monforte/Enrico
Girardi
Netherlands Eline Op de Coul Peter Reiss/Ard van Sighem
Spain Mercedes Diez/Asuncion Diaz Julia Del Amo/Vicky Hernando
Sweden Maria Axelsson Anders Sӧnnerborg
United Kingdom Valerie Delpech Caroline Sabin
Surveillance and cohort leads in participating
countries
Country Surveillance leads Cohort leads
Austria Daniela Schmid/Alexander Spina Robert Zangerle
Belgium Andre Sasse/Dominique Van Beckhoven Andre Sasse/Dominique Van Beckhoven
Denmark Susan Cowan Niels Obel
France Florence Lot/Francoise Cazein Dominique Costagliola/Virginie Supervie
Germany Barbara Bartmeyer Barbara Bartmeyer
Greece Georgios Nikolopoulos Giota Touloumi
Italy Barbara Suligoi Antonella d’ Arminio Monforte/Enrico
Girardi
Netherlands Eline Op de Coul Peter Reiss/Ard van Sighem
Spain Mercedes Diez/Asuncion Diaz Julia Del Amo/Vicky Hernando
Sweden Maria Axelsson Anders Sӧnnerborg
United Kingdom Valerie Delpech Caroline Sabin
Surveillance and cohort leads in participating
countries
 These 11 countries have a combined population of
378.6 million (74% of the EU population)
 The estimated number PLHIV in these 11 countries
= 670 000 (≈80% of all PLHIV in the EU/EEA)
Estimates for HIV continuum using standardised
definitions and surveillance/cohort data, 2013
0%
20%
40%
60%
80%
100%
PLHIV Diagnosed On ART Viral suppression
84%**
84%*
84%*
85%*
**Percentages out of all PLHIV by end 2013*Percentages out of the previous step
Gourlay A, Noori T, Pharris A. et al. The HIV continuum of care in European Union countries in 2013: data and challenges.
Clin Infect Dis 2017 cix212. doi: 10.1093/cid/cix212
71%**
60%**
100%
83%
69%
65%
100%
84%
71%
60%
0%
20%
40%
60%
80%
100%
PLHIV Diagnosed On ART Viral suppression
Continuum of care estimates in the EU/EEA
Dublin (n=18) vs clinical cohort (n=11) estimates
90%
81%
73%
Gourlay A, Noori T, Pharris A. et al. The HIV continuum of care in European Union
countries in 2013: data and challenges. Clin Infect Dis 2017 cix212. doi: 10.1093/cid/cix212
ECDC. Thematic report: HIV continuum of care. Stockholm:
ECDC; 2017. (In press)
Dublin continuum
Cohort continuum
How close are we to reaching the 90-90-90
targets?
100%
81%
68%
60%
100%
84%
73%
65%
100%
61%
34%
24%
0%
20%
40%
60%
80%
100%
PLHIV Diagnosed On ART Viral suppression
Europe and Central Asia EU/EEA Non-EU/EEA
90%
81%
73%
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
How close are we to reaching the 90-90-90
targets?
100%
81%
68%
60%
100%
84%
73%
65%
100%
61%
34%
24%
0%
20%
40%
60%
80%
100%
PLHIV Diagnosed On ART Viral suppression
Europe and Central Asia EU/EEA Non-EU/EEA
90%
81%
73%
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
How close are we to reaching the 90-90-90
targets?
100%
81%
68%
60%
100%
84%
73%
65%
100%
61%
34%
24%
0%
20%
40%
60%
80%
100%
PLHIV Diagnosed On ART Viral suppression
Europe and Central Asia EU/EEA Non-EU/EEA
90%
81%
73%
Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight
HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
Key population continuums
Comparison of the continuum of care for key
populations
100%
83%
70%
63%
100%
82%
57%
40%
100%
73%
51%
41%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
LivingwithHIV
Diagnosed
ReceivingART
Virallysuppressed
LivingwithHIV
Diagnosed
ReceivingART
Virallysuppressed
LivingwithHIV
Diagnosed
ReceivingART
Virallysuppressed
MSM (n=6) PWID (n=7) Foreign born migrants (n=2)
Source: Monitoring the HIV Continuum of Care in key populations across Europe and Central Asia. Submitted for publication.
Comparison of the continuum of care for key
populations against national continua
100%
83%
70%
63%
100%
82%
57%
40%
100%
73%
51%
41%
100%
84%
74%
68%
100%
83%
71%
65%
100%
84%
75%
68%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
LivingwithHIV
Diagnosed
ReceivingART
Virallysuppressed
LivingwithHIV
Diagnosed
ReceivingART
Virallysuppressed
LivingwithHIV
Diagnosed
ReceivingART
Virallysuppressed
MSM (n=6) PWID (n=7) Foreign born migrants (n=2)
Source: Monitoring the HIV Continuum of Care in key populations across Europe and Central Asia. Submitted for publication.
Conclusions
ONTREATMENT
VIRAL
SUPPRESSION
DIAGNOSED
PLHIV There are huge inequalities in HIV treatment and care
 While the EU is closing in on reaching the 90-90-90 targets
 Eastern Europe and Central Asia are lagging far behind
TESTING
LINKAGE &
GUIDELINES
RETENTION AND
ADHERENCE
SUPPORT
35%
OF All PLHIV IN
EU/EEA ARE
NOT VIRALLY
SUPPRESSED
76%
OF All PLHIV IN
EECA ARE NOT
VIRALLY
SUPPRESSED
Acknowledgements
Dublin Declaration advisory group
Irene Rueckerl (Austria), Florence Lot, Daniela Rojas Castro, Richard Stranz (France), Gesa Kupfer (Germany), Derval Igoe (Ireland), Lella Cosmaro (Italy), Silke
David, Eline Op De Coul (Netherlands), Arild Johan Myrberg (Norway), Olivia Castillo (Spain), Maria Axelsson (Sweden), Valerie Delpech, Alison Brown, Cary
James, Brian Rice (United Kingdom), Velina Pendalovska (European Commission), Klaudia Palczak and Dagmar Hedrich (EMCDDA), Taavi Erkkola, Kim Marsh
(UNAIDS) and Annemarie Steengard (WHO Regional Office for Europe).
Dublin Declaration focal points in Europe and Central Asia
Roland Bani (Albania), Montse Gessé (Andorra), Samvel Grigoryan (Armenia), Irene Rueckerl, Bernhard Benka, Robert Zangerle (Austria), Esmira
Almammadova (Azerbaijan), Inna Karabakh (Belarus), Andre Sasse, Dominique Van Beckhoven (Belgium), Šerifa Godinjak (Bosnia and Herzegovina), Tonka
Varleva (Bulgaria), Jasmina Pavlic (Croatia), Ioannis Demetriades (Cyprus), Veronika Šikolová, Hana Janatova (Czech Republic), Jan Fouchard (Denmark), Kristi
Rüütel, Liilia Lõhmus, Anna-Liisa Pääsukene (Estonia), Henrikki Brummer-Korvenkontio (Finland), Bernard Faliu (France), Tamar Kikvidze (Georgia), Gesa
Kupfer, Ulrich Marcus, (Germany), Vasileia Konte, Chryssoula Botsi, Jenny Kremastinou, Theodoros Papadimitriou (Greece), Katalin Szalay (Hungary), Guðrún
Sigmundsdóttir (Iceland), Derval Igoe (Ireland), Daniel Chemtob (Israel), Maria Grazia Pompa, Anna Caraglia, Barbara Suligoi, Laura Camoni, Stefania
D’Amato, Anna Maria Luzi, Anna Colucci, Marco Floridia, Alessandra Cerioli, Lella Cosmaro, Massimo Oldrini, Laura Rancilio, Maria Stagnitta, Michele
Breveglieri, Margherita Errico (Italy), Irina Ivanovna Petrenko (Kazakhstan), Laura Shehu, Pashk Buzhala, Bajram Maxhuni (Kosovo*), Dzhainagul Baiyzbekova
(Kyrgyzstan), Šarlote Konova (Latvia), Irma Caplinskiene (Lithuania), Patrick Hoffman (Luxembourg), Jackie Maistre Melillo (Malta), Violeta Teutu (Moldova),
Aleksandra Marjanovic (Montenegro), Silke David (Netherlands), Arild Johan Myrberg (Norway), Iwona Wawer, Piotr Wysocki, Adam Adamus (Poland),
Antonio Diniz, Teresa Melo (Portugal), Mariana Mardarescu (Romania), Danijela Simic, Sladjana Baros (Serbia), Peter Truska (Slovakia), Irena Klavs (Slovenia),
Olivia Castillo (Spain), Maria Axelsson (Sweden), Stefan Enggist, Axel Schmidt (Switzerland), Muratboky Beknazarov (Tajikistan), Nurcan Ersöz (Turkey),
Valerie Delpech (United Kingdom), Igor Kuzin (Ukraine) and Zulfiya Abdurakhimova (Uzbekistan).
HIV Surveillance focal points in the EU/EEA
Daniela Schmid, Alexander Spina (Austria), Andre Sasse (Belgium), Tonka Varleva (Bulgaria), Tatjana Nemeth Blazic (Croatia); Maria Koliou (Cyprus), Marek
Maly (Czech Republic); Susan Cowan (Denmark), Kristi Ruutel (Estonia), Kirsi Liitsola (Finland), Florence Lot (France), Barbara Gunsenheimer-Bartmeyer
(Germany), Georgios Nikolopoulos and Dimitra Paraskeva (Greece), Maria Dudas (Hungary), Gudrun Sigmundsdottir and Haraldur Briem (Iceland), Kate
O’Donnell and Derval Igoe (Ireland), Barbara Suligoi (Italy), Šarlote Konova (Latvia), Saulius Čaplinskas and Irma Čaplinskienė (Lithuania), : Jean-Claude Schmit
(Luxembourg), Jackie Maistre Melillo and Tanya Melillo (Malta), Eline Op de Coul (Netherlands), Hans Blystad (Norway), Magdalena Rosinska (Poland),
Helena Cortes Martins (Portugal), Mariana Mardarescu (Romania), Peter Truska (Slovakia), Irena Klavs (Slovenia), Asuncion Diaz (Spain), Maria Axelsson
(Sweden), Valerie Delpech (United Kingdom).
EuroCoord/ECDC project collaborators
Daniela Schmid, Alexander Spina, Robert Zangerle (Austria), Andre Sasse, Dominique Van Beckhoven (Belgium), Susan Cowan, Niels Obel (Denmark),
Florence Lot, Francoise Cazein, Dominique Costagliola, Virginie Supervie (France), Barbara Bartmeyer (Germany), Georgios Nikolopoulos, Giota Touloumi
(Greece), Barbara Suligoi, Antonella d’ Arminio Monforte, Enrico Girardi (Italy), Eline Op de Coul, Peter Reiss, Ard van Sighem (Netherlands), Mercedes Diez,
Asuncion Diaz, Julia Del Amo (Spain), Maria Axelsson, Anders Sӧnnerborg (Sweden), Valerie Delpech, Sara Croxford, Caroline Sabin (United Kingdom)
Thank you
teymur.noori@ecdc.europa.eu
anastasia.pharris@ecdc.europa.eu

More Related Content

What's hot

The diverse and dynamic epidemics of hepatitis B and C in the EU: challenges ...
The diverse and dynamic epidemics of hepatitis B and C in the EU: challenges ...The diverse and dynamic epidemics of hepatitis B and C in the EU: challenges ...
The diverse and dynamic epidemics of hepatitis B and C in the EU: challenges ...
European Centre for Disease Prevention and Control
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
European Centre for Disease Prevention and Control
 
The status of HCV prevention among people who inject drugs: an overview of th...
The status of HCV prevention among people who inject drugs: an overview of th...The status of HCV prevention among people who inject drugs: an overview of th...
The status of HCV prevention among people who inject drugs: an overview of th...
European Centre for Disease Prevention and Control
 
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015 World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
European Centre for Disease Prevention and Control
 
HIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europeHIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europe
European Centre for Disease Prevention and Control
 
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
European Centre for Disease Prevention and Control
 
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
European Centre for Disease Prevention and Control
 
graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016
European Centre for Disease Prevention and Control
 
HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015
European Centre for Disease Prevention and Control
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
European Centre for Disease Prevention and Control
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
European Centre for Disease Prevention and Control
 
Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015
Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015
Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015
European Centre for Disease Prevention and Control
 
HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015
European Centre for Disease Prevention and Control
 
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
European Centre for Disease Prevention and Control
 
HIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEAHIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEA
European Centre for Disease Prevention and Control
 
Experience with the implementation of PrEP in France
Experience with the implementation of PrEP in FranceExperience with the implementation of PrEP in France
Experience with the implementation of PrEP in France
European Centre for Disease Prevention and Control
 
Ecdc director elect hearing in the European Parliament
Ecdc director elect hearing in the European ParliamentEcdc director elect hearing in the European Parliament
Ecdc director elect hearing in the European Parliament
European Centre for Disease Prevention and Control
 
Importance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment earlyImportance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment early
European Centre for Disease Prevention and Control
 
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
European Centre for Disease Prevention and Control
 
Priorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspectivePriorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspective
European Centre for Disease Prevention and Control
 

What's hot (20)

The diverse and dynamic epidemics of hepatitis B and C in the EU: challenges ...
The diverse and dynamic epidemics of hepatitis B and C in the EU: challenges ...The diverse and dynamic epidemics of hepatitis B and C in the EU: challenges ...
The diverse and dynamic epidemics of hepatitis B and C in the EU: challenges ...
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
 
The status of HCV prevention among people who inject drugs: an overview of th...
The status of HCV prevention among people who inject drugs: an overview of th...The status of HCV prevention among people who inject drugs: an overview of th...
The status of HCV prevention among people who inject drugs: an overview of th...
 
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015 World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
 
HIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europeHIV: Reaching the 90-90-90 targets in europe
HIV: Reaching the 90-90-90 targets in europe
 
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
 
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
 
graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016graphics trends for ecdc measles and rubella monitoring, 2013 2016
graphics trends for ecdc measles and rubella monitoring, 2013 2016
 
HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
 
Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015
Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015
Vaccination in the EU, ENVI Committee, European Parliament 17 June 2015
 
HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015
 
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
 
HIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEAHIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEA
 
Experience with the implementation of PrEP in France
Experience with the implementation of PrEP in FranceExperience with the implementation of PrEP in France
Experience with the implementation of PrEP in France
 
Ecdc director elect hearing in the European Parliament
Ecdc director elect hearing in the European ParliamentEcdc director elect hearing in the European Parliament
Ecdc director elect hearing in the European Parliament
 
Importance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment earlyImportance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment early
 
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
Is shigellosis among MSM a widespread problem? An analysis of EU/EEA surveill...
 
Priorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspectivePriorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspective
 

Similar to How are countries in Europe and Central Asia performing against the UNAIDS 90-90-90 Targets?

90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
European Centre for Disease Prevention and Control
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
European Centre for Disease Prevention and Control
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
European Centre for Disease Prevention and Control
 
Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018
European Centre for Disease Prevention and Control
 
Fast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in EuropeFast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in Europe
European Centre for Disease Prevention and Control
 
Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...
European Centre for Disease Prevention and Control
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
European Centre for Disease Prevention and Control
 
World TB Day 2017 - presentation
World TB Day 2017 - presentationWorld TB Day 2017 - presentation
World TB Day 2017 - presentation
WHO Regional Office for Europe
 
Regional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausRegional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve Kraus
Dr. Rubz
 
European approach - HA-REACT Joint Action as an exmple_eng
European approach - HA-REACT Joint Action as an exmple_engEuropean approach - HA-REACT Joint Action as an exmple_eng
European approach - HA-REACT Joint Action as an exmple_eng
THL
 
Latest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDCLatest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDC
European Centre for Disease Prevention and Control
 
Challenges of fighting viral hepatitis in Europe - ECDC at IUSTI Europe 2016
Challenges of fighting viral hepatitis  in Europe - ECDC at IUSTI Europe 2016Challenges of fighting viral hepatitis  in Europe - ECDC at IUSTI Europe 2016
Challenges of fighting viral hepatitis in Europe - ECDC at IUSTI Europe 2016
European Centre for Disease Prevention and Control
 
07 Trend in ethiopia for last 26 years.pdf
07 Trend in ethiopia for last 26 years.pdf07 Trend in ethiopia for last 26 years.pdf
07 Trend in ethiopia for last 26 years.pdf
AMANUELMELAKU5
 
The HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura WatersThe HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura Waters
ReShape
 
Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...
hivlifeinfo
 
current hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overviewcurrent hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overview
ikramdr01
 
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
European Centre for Disease Prevention and Control
 
2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf
HajrahHajrah5
 
Monitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countriesMonitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countries
European Centre for Disease Prevention and Control
 
guidelinesmeasuringpopulation
guidelinesmeasuringpopulationguidelinesmeasuringpopulation
guidelinesmeasuringpopulationVelma Lopez
 

Similar to How are countries in Europe and Central Asia performing against the UNAIDS 90-90-90 Targets? (20)

90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018Overview of the HIV continuum of care in Europe and Central Asia, 2018
Overview of the HIV continuum of care in Europe and Central Asia, 2018
 
Fast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in EuropeFast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in Europe
 
Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...Addressing the first 90: How can HIV testing more efficiently reach those in ...
Addressing the first 90: How can HIV testing more efficiently reach those in ...
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
 
World TB Day 2017 - presentation
World TB Day 2017 - presentationWorld TB Day 2017 - presentation
World TB Day 2017 - presentation
 
Regional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausRegional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve Kraus
 
European approach - HA-REACT Joint Action as an exmple_eng
European approach - HA-REACT Joint Action as an exmple_engEuropean approach - HA-REACT Joint Action as an exmple_eng
European approach - HA-REACT Joint Action as an exmple_eng
 
Latest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDCLatest epidemiology on migrants in the European Union - ECDC
Latest epidemiology on migrants in the European Union - ECDC
 
Challenges of fighting viral hepatitis in Europe - ECDC at IUSTI Europe 2016
Challenges of fighting viral hepatitis  in Europe - ECDC at IUSTI Europe 2016Challenges of fighting viral hepatitis  in Europe - ECDC at IUSTI Europe 2016
Challenges of fighting viral hepatitis in Europe - ECDC at IUSTI Europe 2016
 
07 Trend in ethiopia for last 26 years.pdf
07 Trend in ethiopia for last 26 years.pdf07 Trend in ethiopia for last 26 years.pdf
07 Trend in ethiopia for last 26 years.pdf
 
The HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura WatersThe HIV Cascade - Dr Laura Waters
The HIV Cascade - Dr Laura Waters
 
Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...Антиретровирусное лечение – перспективы Европейского клинического общества по...
Антиретровирусное лечение – перспективы Европейского клинического общества по...
 
current hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overviewcurrent hiv situation in india and national aids control programme an overview
current hiv situation in india and national aids control programme an overview
 
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
Tuberculosis and HIV co-infection in the European Union: Epidemiology and tre...
 
2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf2019-cde-ias-hepatitis-c-elimination.pdf
2019-cde-ias-hepatitis-c-elimination.pdf
 
Monitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countriesMonitoring viral hepatitis elimination across EU/EEA countries
Monitoring viral hepatitis elimination across EU/EEA countries
 
guidelinesmeasuringpopulation
guidelinesmeasuringpopulationguidelinesmeasuringpopulation
guidelinesmeasuringpopulation
 

More from European Centre for Disease Prevention and Control

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
European Centre for Disease Prevention and Control
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
European Centre for Disease Prevention and Control
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
European Centre for Disease Prevention and Control
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
European Centre for Disease Prevention and Control
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
European Centre for Disease Prevention and Control
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
European Centre for Disease Prevention and Control
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
European Centre for Disease Prevention and Control
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
European Centre for Disease Prevention and Control
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
European Centre for Disease Prevention and Control
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
European Centre for Disease Prevention and Control
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
European Centre for Disease Prevention and Control
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
European Centre for Disease Prevention and Control
 
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
European Centre for Disease Prevention and Control
 
Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...
European Centre for Disease Prevention and Control
 
Addressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in careAddressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in care
European Centre for Disease Prevention and Control
 
Hepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 dataHepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 data
European Centre for Disease Prevention and Control
 

More from European Centre for Disease Prevention and Control (20)

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
The use, and likelihood of using, HIV pre-exposure prophylaxis among men who ...
 
Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...Addressing the second 90: How can treatment scale-up across the European regi...
Addressing the second 90: How can treatment scale-up across the European regi...
 
Addressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in careAddressing the third 90: Improving clinical outcomes and retention in care
Addressing the third 90: Improving clinical outcomes and retention in care
 
Hepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 dataHepatitis B and C surveillance in the EU/EEA, 2016 data
Hepatitis B and C surveillance in the EU/EEA, 2016 data
 

Recently uploaded

The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 

Recently uploaded (20)

The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 

How are countries in Europe and Central Asia performing against the UNAIDS 90-90-90 Targets?

  • 1. How are countries in Europe and Central Asia performing against the UNAIDS 90-90-90 Targets? Teymur Noori and Anastasia Pharris European Centre for Disease Prevention and Control EACS 2017 25-27 October, 2017
  • 2. Fast Track Targets by 2020 73% of all people living with HIV VIRALLY SUPPRESSED = Target 1 Target 2 Target 3 Overall target diagnosed with HIV ON ART living with HIV DIAGNOSED on ART VIRALLY SUPPRESSED
  • 3. Fast Track Targets by 2020 73% of all people living with HIV VIRALLY SUPPRESSED = Target 1 Target 2 Target 3 diagnosed with HIV ON ART living with HIV DIAGNOSED on ART VIRALLY SUPPRESSED Overall target
  • 4. Progress toward achieving the first 90: Target 1: 90% of all PLHIV who know their status (n=36) Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% UNAIDS target 90% Regional average 75%
  • 5. Progress toward achieving the first 90: Target 1: 90% of all PLHIV who know their status (n=36) Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% UNAIDS target 90% EU/EEA average 83% Non-EU average 58%
  • 6. Source: ECDC/WHO Europe (2016). HIV/AIDS Surveillance in Europe, 2015 Too many people living with HIV are diagnosed late *CD4<350 at diagnosis
  • 7. Are new innovative approaches to HIV testing included in national HIV testing guidelines? (n=47) Testing types Yes No No guidelines Community-based testing delivered by trained medical staff 27 10 10 Community-based testing delivered by non- medical staff (e.g. trained lay people) 11 26 10 Home-sampling kits 3 34 10 Self-testing kits 2 35 10 Source: ECDC. HIV testing in Europe. Stockholm: ECDC; 2017.
  • 8. Fast Track Targets by 2020 73% of all people living with HIV VIRALLY SUPPRESSED = Target 1 Target 2 Target 3 diagnosed with HIV ON ART living with HIV DIAGNOSED on ART VIRALLY SUPPRESSED Overall target
  • 9. Progress toward achieving the second 90: Target 2: 90% of those diagnosed on ART (n=40) Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Regional average 78% UNAIDS target 90%
  • 10. Progress toward achieving the second 90: Target 2: 90% of those diagnosed on ART (n=40) Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% UNAIDS target 90% EU/EEA average 85% Non-EU average 53%
  • 11. Policies on ART initiation in European countries 2014 (n=48) 2015 Source: ECDC. HIV treatment and care. Stockholm: ECDC; 2017. 4 29 15 1028 8 1 0 5 10 15 20 25 30 35 40 45 50 2014 2016 Numberofcountries/ARTpolicy 200 cells/mm3 350 cells/mm3 500 cells/mm3 Initiation regardless of CD4 count
  • 12. Policies on ART initiation in European countries 2014 (n=48) 2015 Source: ECDC. HIV treatment and care. Stockholm: ECDC; 2017. 4 29 15 1028 8 1 0 5 10 15 20 25 30 35 40 45 50 2014 2016 Numberofcountries/ARTpolicy 200 cells/mm3 350 cells/mm3 500 cells/mm3 Initiation regardless of CD4 count
  • 13. Policies on ART initiation in European countries 2014 (n=48) and 2016 (n=47) 2015 Source: ECDC. HIV treatment and care. Stockholm: ECDC; 2017. 4 29 15 1028 8 1 0 5 10 15 20 25 30 35 40 45 50 2014 2016 Numberofcountries/ARTpolicy 200 cells/mm3 350 cells/mm3 500 cells/mm3 Initiation regardless of CD4 count
  • 14. Availability of ART for undocumented migrants, 2016 Source: ECDC. From Dublin to Rome: ten years of responding to HIV in Europe and Central Asia: Stockholm, ECDC; 2014 Source: ECDC. HIV and migrants. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report Stockholm: ECDC; 2017.
  • 15. Fast Track Targets by 2020 73% of all people living with HIV VIRALLY SUPPRESSED = Target 1 Target 2 Target 3 diagnosed with HIV ON ART living with HIV DIAGNOSED on ART VIRALLY SUPPRESSED Overall target
  • 16. Progress toward achieving the third 90: Target 3: 90% of those on ART virally suppressed (n=31) Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Regional average 88% UNAIDS target 90%
  • 17. Progress toward achieving the third 90: Target 3: 90% of those on ART virally suppressed (n=31) Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% UNAIDS target 90% EU/EEA average 89% Non-EU average 71%
  • 18. Fast Track Targets by 2020 73% of all people living with HIV VIRALLY SUPPRESSED = Target 1 Target 2 Target 3 diagnosed with HIV ON ART living with HIV DIAGNOSED on ART VIRALLY SUPPRESSED Overall target
  • 19. Progress toward achieving the 90-90-90: Target 4: 73% of all PLHIV virally suppressed (n=29) Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Regional average 60% UNAIDS target 73%
  • 20. Progress toward achieving the 90-90-90: Target 4: 73% of all PLHIV virally suppressed (n=29) Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% UNAIDS target 73% EU/EEA average 65% Non-EU average 24%
  • 21. Rate of new HIV diagnoses EU/EEA vs. non-EU/EEA countries, 2006–2015 +105% Source: ECDC/WHO Europe (2016). HIV/AIDS Surveillance in Europe, 2015
  • 22. Can we produce an EU continuum of care estimate based on country reported data?  Variability of data availability, quality, sources and measurement have historically made it difficult to compare and combine results across countries  But…
  • 23. EuroCoord/ECDC collaboration on estimating the continuum of care  ECDC project with UCL & EuroCoord on estimating the continuum of care using surveillance and cohort data  Using standard definitions and high quality data sources Gourlay A, Noori T, Pharris A. et al. The HIV continuum of care in European Union countries in 2013: data and challenges. Clin Infect Dis 2017 cix212. doi: 10.1093/cid/cix212
  • 24. PLHIV Diagnosed On ART Viral suppression Clinical/ cohort data Public health/ surveillance data Bringing together HIV surveillance and clinical data
  • 25. Country Surveillance leads Cohort leads Austria Daniela Schmid/Alexander Spina Robert Zangerle Belgium Andre Sasse/Dominique Van Beckhoven Andre Sasse/Dominique Van Beckhoven Denmark Susan Cowan Niels Obel France Florence Lot/Francoise Cazein Dominique Costagliola/Virginie Supervie Germany Barbara Gunsenheimer-Bartmeyer Barbara Gunsenheimer-Bartmeyer Greece Georgios Nikolopoulos Giota Touloumi Italy Barbara Suligoi Antonella d’ Arminio Monforte/Enrico Girardi Netherlands Eline Op de Coul Peter Reiss/Ard van Sighem Spain Mercedes Diez/Asuncion Diaz Julia Del Amo/Vicky Hernando Sweden Maria Axelsson Anders Sӧnnerborg United Kingdom Valerie Delpech Caroline Sabin Surveillance and cohort leads in participating countries
  • 26. Country Surveillance leads Cohort leads Austria Daniela Schmid/Alexander Spina Robert Zangerle Belgium Andre Sasse/Dominique Van Beckhoven Andre Sasse/Dominique Van Beckhoven Denmark Susan Cowan Niels Obel France Florence Lot/Francoise Cazein Dominique Costagliola/Virginie Supervie Germany Barbara Bartmeyer Barbara Bartmeyer Greece Georgios Nikolopoulos Giota Touloumi Italy Barbara Suligoi Antonella d’ Arminio Monforte/Enrico Girardi Netherlands Eline Op de Coul Peter Reiss/Ard van Sighem Spain Mercedes Diez/Asuncion Diaz Julia Del Amo/Vicky Hernando Sweden Maria Axelsson Anders Sӧnnerborg United Kingdom Valerie Delpech Caroline Sabin Surveillance and cohort leads in participating countries  These 11 countries have a combined population of 378.6 million (74% of the EU population)  The estimated number PLHIV in these 11 countries = 670 000 (≈80% of all PLHIV in the EU/EEA)
  • 27. Estimates for HIV continuum using standardised definitions and surveillance/cohort data, 2013 0% 20% 40% 60% 80% 100% PLHIV Diagnosed On ART Viral suppression 84%** 84%* 84%* 85%* **Percentages out of all PLHIV by end 2013*Percentages out of the previous step Gourlay A, Noori T, Pharris A. et al. The HIV continuum of care in European Union countries in 2013: data and challenges. Clin Infect Dis 2017 cix212. doi: 10.1093/cid/cix212 71%** 60%**
  • 28. 100% 83% 69% 65% 100% 84% 71% 60% 0% 20% 40% 60% 80% 100% PLHIV Diagnosed On ART Viral suppression Continuum of care estimates in the EU/EEA Dublin (n=18) vs clinical cohort (n=11) estimates 90% 81% 73% Gourlay A, Noori T, Pharris A. et al. The HIV continuum of care in European Union countries in 2013: data and challenges. Clin Infect Dis 2017 cix212. doi: 10.1093/cid/cix212 ECDC. Thematic report: HIV continuum of care. Stockholm: ECDC; 2017. (In press) Dublin continuum Cohort continuum
  • 29. How close are we to reaching the 90-90-90 targets? 100% 81% 68% 60% 100% 84% 73% 65% 100% 61% 34% 24% 0% 20% 40% 60% 80% 100% PLHIV Diagnosed On ART Viral suppression Europe and Central Asia EU/EEA Non-EU/EEA 90% 81% 73% Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
  • 30. How close are we to reaching the 90-90-90 targets? 100% 81% 68% 60% 100% 84% 73% 65% 100% 61% 34% 24% 0% 20% 40% 60% 80% 100% PLHIV Diagnosed On ART Viral suppression Europe and Central Asia EU/EEA Non-EU/EEA 90% 81% 73% Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
  • 31. How close are we to reaching the 90-90-90 targets? 100% 81% 68% 60% 100% 84% 73% 65% 100% 61% 34% 24% 0% 20% 40% 60% 80% 100% PLHIV Diagnosed On ART Viral suppression Europe and Central Asia EU/EEA Non-EU/EEA 90% 81% 73% Source: ECDC. Thematic report: HIV continuum of care. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2017 progress report. Stockholm: ECDC; 2017. (In press)
  • 33. Comparison of the continuum of care for key populations 100% 83% 70% 63% 100% 82% 57% 40% 100% 73% 51% 41% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% LivingwithHIV Diagnosed ReceivingART Virallysuppressed LivingwithHIV Diagnosed ReceivingART Virallysuppressed LivingwithHIV Diagnosed ReceivingART Virallysuppressed MSM (n=6) PWID (n=7) Foreign born migrants (n=2) Source: Monitoring the HIV Continuum of Care in key populations across Europe and Central Asia. Submitted for publication.
  • 34. Comparison of the continuum of care for key populations against national continua 100% 83% 70% 63% 100% 82% 57% 40% 100% 73% 51% 41% 100% 84% 74% 68% 100% 83% 71% 65% 100% 84% 75% 68% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% LivingwithHIV Diagnosed ReceivingART Virallysuppressed LivingwithHIV Diagnosed ReceivingART Virallysuppressed LivingwithHIV Diagnosed ReceivingART Virallysuppressed MSM (n=6) PWID (n=7) Foreign born migrants (n=2) Source: Monitoring the HIV Continuum of Care in key populations across Europe and Central Asia. Submitted for publication.
  • 35. Conclusions ONTREATMENT VIRAL SUPPRESSION DIAGNOSED PLHIV There are huge inequalities in HIV treatment and care  While the EU is closing in on reaching the 90-90-90 targets  Eastern Europe and Central Asia are lagging far behind TESTING LINKAGE & GUIDELINES RETENTION AND ADHERENCE SUPPORT 35% OF All PLHIV IN EU/EEA ARE NOT VIRALLY SUPPRESSED 76% OF All PLHIV IN EECA ARE NOT VIRALLY SUPPRESSED
  • 36. Acknowledgements Dublin Declaration advisory group Irene Rueckerl (Austria), Florence Lot, Daniela Rojas Castro, Richard Stranz (France), Gesa Kupfer (Germany), Derval Igoe (Ireland), Lella Cosmaro (Italy), Silke David, Eline Op De Coul (Netherlands), Arild Johan Myrberg (Norway), Olivia Castillo (Spain), Maria Axelsson (Sweden), Valerie Delpech, Alison Brown, Cary James, Brian Rice (United Kingdom), Velina Pendalovska (European Commission), Klaudia Palczak and Dagmar Hedrich (EMCDDA), Taavi Erkkola, Kim Marsh (UNAIDS) and Annemarie Steengard (WHO Regional Office for Europe). Dublin Declaration focal points in Europe and Central Asia Roland Bani (Albania), Montse Gessé (Andorra), Samvel Grigoryan (Armenia), Irene Rueckerl, Bernhard Benka, Robert Zangerle (Austria), Esmira Almammadova (Azerbaijan), Inna Karabakh (Belarus), Andre Sasse, Dominique Van Beckhoven (Belgium), Šerifa Godinjak (Bosnia and Herzegovina), Tonka Varleva (Bulgaria), Jasmina Pavlic (Croatia), Ioannis Demetriades (Cyprus), Veronika Šikolová, Hana Janatova (Czech Republic), Jan Fouchard (Denmark), Kristi Rüütel, Liilia Lõhmus, Anna-Liisa Pääsukene (Estonia), Henrikki Brummer-Korvenkontio (Finland), Bernard Faliu (France), Tamar Kikvidze (Georgia), Gesa Kupfer, Ulrich Marcus, (Germany), Vasileia Konte, Chryssoula Botsi, Jenny Kremastinou, Theodoros Papadimitriou (Greece), Katalin Szalay (Hungary), Guðrún Sigmundsdóttir (Iceland), Derval Igoe (Ireland), Daniel Chemtob (Israel), Maria Grazia Pompa, Anna Caraglia, Barbara Suligoi, Laura Camoni, Stefania D’Amato, Anna Maria Luzi, Anna Colucci, Marco Floridia, Alessandra Cerioli, Lella Cosmaro, Massimo Oldrini, Laura Rancilio, Maria Stagnitta, Michele Breveglieri, Margherita Errico (Italy), Irina Ivanovna Petrenko (Kazakhstan), Laura Shehu, Pashk Buzhala, Bajram Maxhuni (Kosovo*), Dzhainagul Baiyzbekova (Kyrgyzstan), Šarlote Konova (Latvia), Irma Caplinskiene (Lithuania), Patrick Hoffman (Luxembourg), Jackie Maistre Melillo (Malta), Violeta Teutu (Moldova), Aleksandra Marjanovic (Montenegro), Silke David (Netherlands), Arild Johan Myrberg (Norway), Iwona Wawer, Piotr Wysocki, Adam Adamus (Poland), Antonio Diniz, Teresa Melo (Portugal), Mariana Mardarescu (Romania), Danijela Simic, Sladjana Baros (Serbia), Peter Truska (Slovakia), Irena Klavs (Slovenia), Olivia Castillo (Spain), Maria Axelsson (Sweden), Stefan Enggist, Axel Schmidt (Switzerland), Muratboky Beknazarov (Tajikistan), Nurcan Ersöz (Turkey), Valerie Delpech (United Kingdom), Igor Kuzin (Ukraine) and Zulfiya Abdurakhimova (Uzbekistan). HIV Surveillance focal points in the EU/EEA Daniela Schmid, Alexander Spina (Austria), Andre Sasse (Belgium), Tonka Varleva (Bulgaria), Tatjana Nemeth Blazic (Croatia); Maria Koliou (Cyprus), Marek Maly (Czech Republic); Susan Cowan (Denmark), Kristi Ruutel (Estonia), Kirsi Liitsola (Finland), Florence Lot (France), Barbara Gunsenheimer-Bartmeyer (Germany), Georgios Nikolopoulos and Dimitra Paraskeva (Greece), Maria Dudas (Hungary), Gudrun Sigmundsdottir and Haraldur Briem (Iceland), Kate O’Donnell and Derval Igoe (Ireland), Barbara Suligoi (Italy), Šarlote Konova (Latvia), Saulius Čaplinskas and Irma Čaplinskienė (Lithuania), : Jean-Claude Schmit (Luxembourg), Jackie Maistre Melillo and Tanya Melillo (Malta), Eline Op de Coul (Netherlands), Hans Blystad (Norway), Magdalena Rosinska (Poland), Helena Cortes Martins (Portugal), Mariana Mardarescu (Romania), Peter Truska (Slovakia), Irena Klavs (Slovenia), Asuncion Diaz (Spain), Maria Axelsson (Sweden), Valerie Delpech (United Kingdom). EuroCoord/ECDC project collaborators Daniela Schmid, Alexander Spina, Robert Zangerle (Austria), Andre Sasse, Dominique Van Beckhoven (Belgium), Susan Cowan, Niels Obel (Denmark), Florence Lot, Francoise Cazein, Dominique Costagliola, Virginie Supervie (France), Barbara Bartmeyer (Germany), Georgios Nikolopoulos, Giota Touloumi (Greece), Barbara Suligoi, Antonella d’ Arminio Monforte, Enrico Girardi (Italy), Eline Op de Coul, Peter Reiss, Ard van Sighem (Netherlands), Mercedes Diez, Asuncion Diaz, Julia Del Amo (Spain), Maria Axelsson, Anders Sӧnnerborg (Sweden), Valerie Delpech, Sara Croxford, Caroline Sabin (United Kingdom)